Article
A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance.
Journal of medical genetics - 1 Jan 2014
van der Tol L, Smid B E, Poorthuis B J H M, Biegstraaten M, Deprez R H Lekanne, Linthorst G E, Hollak C E M
Abstract excerpt
Screening for Fabry disease (FD) reveals a high prevalence of individuals with α-galactosidase A (GLA) genetic variants of unknown significance (GVUS). These individuals often do not express characteristic features of FD. A systematic review on FD screening studies was performed to interpret the significance of GLA gene variants and to calculate the prevalence of definite classical and uncertain cases. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
